Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medigrow Africa is an active private medical cannabis company focused on cultivating, processing, and exporting pharmaceutical-grade cannabis products from Africa. The company describes itself as a formal network of legal African cannabis growers supplying international-grade medical cannabis for global distribution, with operations and partnerships across South Africa and broader African markets. Its business model combines cultivation management, licensing support, quality systems, processing, extraction, packaging, and commercialization of cannabis-derived oils and related products. Medigrow also operates a healthcare access channel for patients and has promoted exports to international markets, particularly Europe and other regulated jurisdictions. The company appears to be commercially focused rather than a traditional drug-development biotech, with emphasis on medicinal cannabis supply infrastructure rather than a disclosed molecule-by-molecule clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medigrow Africa.